Page last updated: 2024-10-23

bethanechol and Amphetamine-Related Disorders

bethanechol has been researched along with Amphetamine-Related Disorders in 1 studies

Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research Excerpts

ExcerptRelevanceReference
"We report a case of neurogenic bladder and chronic urinary retention associated with MDMA abuse."1.35Neurogenic bladder and chronic urinary retention associated with MDMA abuse. ( Barrueto, F; Beuerle, JR, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beuerle, JR1
Barrueto, F1

Other Studies

1 other study available for bethanechol and Amphetamine-Related Disorders

ArticleYear
Neurogenic bladder and chronic urinary retention associated with MDMA abuse.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2008, Volume: 4, Issue:2

    Topics: Adult; Amphetamine-Related Disorders; Anti-Infective Agents, Urinary; Bethanechol; Central Nervous S

2008